
|Articles|February 12, 2013
Richard Stefanacci, DO, Discusses Trends in Neurodegenerative Diseases
Richard Stefanacci, DO, associate professor, Health Policy & Public Health, University of the Sciences, says that scanning and diagnostic testing are currently the most popular trend in neurodegenerative diseases.
Advertisement
Richard Stefanacci, DO, associate professor, Health Policy & Public Health, University of the Sciences, says that scanning and diagnostic testing are currently the most popular trend in neurodegenerative diseases.
There are new technologies being utilized, but it is important they are used on the right patients at the right time. "It requires the plans to educate providers to make sure they are identifiying the right patients in doing these tests," said Dr Stefanacci.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
5 Things to Know About Retatrutide, the "Trillion-Dollar" Drug
2
Sarcoma Gene Signature May Predict Who Benefits From Pazopanib
3
GLP-1 Use Remains Rare Among Eligible Patients With Multiple Sclerosis
4
Lifestyle Factors Offer Actionable Targets in MASLD Management: Zobair M. Younossi, MD
5




